surmount 2 tirzepatide Efficacy and safety of once‐weekly in Japanese participants with type diabetes who have obesity or overweight: Subpopulation analysis of the SURMOUNT‐2 trial - Yamauchi - 2025 SURMOUNT 1 // Three-Year Obesty
Description
Blood 113 , 11121121 (2009)
And theyre even exploring versions that are now, you know, triple
[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Sun L., Shang B., Lv S., Liu G., Wu Q., Geng Y
And the off-label extras you might be counting on, the heart data especially, belong to semaglutide, not to the new pill
